Patents : |  |
| US Patent No. | Title |
| 7385042 | Therapeutic and diagnostic compounds, compositions, and methods
|
| 7452996 | Substituted quinoline derivatives
|
| 7459531 | 50 Human secreted proteins
|
| 7468363 | Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
| 7468379 | Inhibition of osteolytic lesions by SRC kinase inhibitors
|
| 7470701 | Substituted 2,5-heterocyclic derivatives
|
| 7473528 | Method for the detection of Chagas disease related gene transcripts in blood
|
| 7482147 | Ubiquitin protease
|
| 7482442 | HEMCM42 nucleic acids
|
| 7495112 | Isoindoline compounds and methods of making and using the same
|
| 7498565 | Method of and system for selective cell destruction
|
| 7449555 | Antibodies of angiogenesis inhibiting domains CD148
|
| 7442778 | Modified Fc molecules
|
| 7442514 | Mutants of the factor VII-activating protease and detection methods using specific antibodies
|
| 7393862 | Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
|
| 7402666 | Nucleotide encoding canine 5T4 antigen
|
| 7405237 | Isoindoline compounds and methods of their use
|
| 7408046 | Treatment of bone-associated cancers
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7411052 | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
|
| 7411054 | 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
|
| 7413864 | Treating cancer using a telomerase vaccine
|
| 7422741 | VEGFR-3 fusion proteins
|
| 7425610 | Methods and materials relating to CD84-like polypeptides and polynucleotides
|
| 7504405 | Mitotic kinesin inhibitors
|
| 7504427 | Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
|
| 7576066 | Nucleic acid compositions for stimulating immune responses
|
| 7576221 | Substituted imidazole derivatives
|
| 7579313 | Transglutaminase inhibitors and methods of use thereof
|
| 7585622 | Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7601355 | Compositions and methods for altering immune function
|
| 7605138 | Nucleic acid compositions for stimulating immune responses
|
| 7605239 | Skeletal-targeted radiation to treat bone-associated pathologies
|
| 7608618 | Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
|
| 7608723 | Indole and benzimidazole derivatives
|
| 7569597 | Isoindoline compounds and methods of their use
|
| 7569553 | Nucleic acid compositions for stimulating immune responses
|
| 7560462 | Compounds useful for inhibiting CHK1
|
| 7504431 | Sulfonyl amide inhibitors of calcium channel function
|
| 7507410 | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
|
| 7511072 | 7-amido-isoindolyl compounds and methods of its use
|
| 7517971 | Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
|
| 7521053 | Angiopoietin-2 specific binding agents
|
| 7534772 | Methods for enhancing antibody-induced cell lysis and treating cancer
|
| 7537911 | ATM related kinase, ATX, nucleic acids encoding same and methods of use
|
| 7538095 | Genetic inhibition by double-stranded RNA
|
| 7560437 | Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
|
| 7560438 | Genetic inhibition by double-stranded RNA
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
